Samsung Biologics labor dispute drags on as union stages another strike
Samsung Biologics' unionized workers staged another strike Friday, as wage and collective bargaining negotiations between labor and management have dragged on for more than six months. With global rivals moving quickly to expand their contract drug manufacturing capability, concerns are growing that the prolonged labor dispute could undermine Samsung Biologics' reputation as a reliable supplier…
Samsung Biologics union workers walked off the job on Friday, reigniting a labor dispute that has persisted for over six months. The ongoing negotiations between labor and management have raised concerns that the prolonged impasse could tarnish the company's reputation as a dependable supplier of drugs. The Samsung Biologics labor union initiated the strike, which is expected to last approximately three weeks until November 27.
Around 400 employees, representing 10 percent of the union's 4,000 members, are participating in the action. These workers are stationed in various departments, such as quality control testing, quality assurance, logistics, and production. In March, Samsung Biologics' labor and management declared their 2026 wage and collective bargaining negotiations had broken down, leading to the first partial strike since the company's inception in 2011.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Samsung Biologics Union Begins Second Partial Strike businesskorea.co.kr
- Samsung Biologics labor dispute drags on as union stages another strike koreatimes.co.kr
- Unionized members at Samsung Biologics stage another partial strike en.yna.co.kr
